The Wuhan SARS‐CoV‐2—What's next for China

Abstract

Journal of Medical VirologyVolume 92, Issue 6 p. 546-547 COMMENTARY The Wuhan SARS-CoV-2—What's next for China Hongzhou Lu, Corresponding Author Hongzhou Lu luhongzhou@fudan.edu.cn Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China Correspondence Hongzhou Lu, Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang Hwy, Shanghai 201508, China. Email: luhongzhou@fudan.edu.cn Yi-Wei Tang, Cepheid, Danaher Diagnostic Platform, 518 Fuquan N Rd, Shanghai 200325, China. Email: yi-wei.tang@cepheid.comSearch for more papers by this authorCharles W. Stratton, Charles W. Stratton Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TennesseeSearch for more papers by this authorYi-Wei Tang, Corresponding Author Yi-Wei Tang yi-wei.tang@cepheid.com orcid.org/0000-0003-4888-6771 Cepheid, Danaher Diagnostic Platform, Shanghai, China Correspondence Hongzhou Lu, Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang Hwy, Shanghai 201508, China. Email: luhongzhou@fudan.edu.cn Yi-Wei Tang, Cepheid, Danaher Diagnostic Platform, 518 Fuquan N Rd, Shanghai 200325, China. Email: yi-wei.tang@cepheid.comSearch for more papers by this author Hongzhou Lu, Corresponding Author Hongzhou Lu luhongzhou@fudan.edu.cn Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China Correspondence Hongzhou Lu, Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang Hwy, Shanghai 201508, China. Email: luhongzhou@fudan.edu.cn Yi-Wei Tang, Cepheid, Danaher Diagnostic Platform, 518 Fuquan N Rd, Shanghai 200325, China. Email: yi-wei.tang@cepheid.comSearch for more papers by this authorCharles W. Stratton, Charles W. Stratton Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TennesseeSearch for more papers by this authorYi-Wei Tang, Corresponding Author Yi-Wei Tang yi-wei.tang@cepheid.com orcid.org/0000-0003-4888-6771 Cepheid, Danaher Diagnostic Platform, Shanghai, China Correspondence Hongzhou Lu, Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, 2901 Caolang Hwy, Shanghai 201508, China. Email: luhongzhou@fudan.edu.cn Yi-Wei Tang, Cepheid, Danaher Diagnostic Platform, 518 Fuquan N Rd, Shanghai 200325, China. Email: yi-wei.tang@cepheid.comSearch for more papers by this author First published: 01 March 2020 https://doi.org/10.1002/jmv.25738Citations: 29Read the full textAboutRelatedInformationPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessClose modalShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume92, Issue6Special Issue on New coronavirus (2019‐nCoV or SARS‐CoV‐2) and the outbreak of the respiratory illness (COVID‐19): Part‐IIIJune 2020Pages 546-547 RelatedInformation RecommendedThe unique features of SARS‐CoV‐2 transmission: Comparison with SARS‐CoV, MERS‐CoV and 2009 H1N1 pandemic influenza virusZhonglan Wu, David Harrich, Zhongyang Li, Dongsheng Hu, Dongsheng Li, Reviews in Medical VirologyAnimal coronaviruses and SARS‐CoV‐2Guangzhi Zhang, Bin Li, Dongwan Yoo, Tong Qin, Xiaodong Zhang, Yaxiong Jia, Shangjin Cui, Transboundary and Emerging DiseasesWhich influenza viruses will emerge following the SARS‐CoV‐2 pandemic?Karen L. Laurie, Steve Rockman, Influenza and Other Respiratory VirusesOutbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracleHongzhou Lu, Charles W. Stratton, Yi-Wei Tang, Journal of Medical VirologyPathogenesis‐directed therapy of 2019 novel coronavirus diseaseCharles W. Stratton, Yi-Wei Tang, Hongzhou Lu, Journal of Medical Virology